ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Anti-spasmodic Drugs Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-9L6046
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Anti spasmodic Drugs Market Insights and Forecast to 2028
BUY CHAPTERS

Global Anti-spasmodic Drugs Market Research Report 2025

Code: QYRE-Auto-9L6046
Report
July 2025
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Allergan plc
Ipsen S A
Teva Pharmaceuticals
Novartis
Johnson & Johnson
Takeda Pharmaceutical
Sun Pharmaceutical Industries
Merz Pharma
Mylan NV
Fresenius Kabi
Endo International
Daewoong Pharmaceutical
Acorda Therapeutics
Sterimax
Emcure Pharmaceuticals
Sawai Pharmaceutical
Orient Pharma
Johnson & Johnson

Anti-spasmodic Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Anti-spasmodic Drugs Market

Anti-spasmodic Drugs Market

The global market for Anti-spasmodic Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Antispasmodic drugs such as dicyclomine (Bentyl) and hyoscyamine (Levsin) relieve the stomach cramps brought on by IBS by relaxing the smooth muscle of the gut. They also may cause constipation, so they aren"t usually prescribed for people who suffer from IBS-C. Other side effects are dry mouth, drowsiness, and blurred vision.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Anti-spasmodic Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Anti-spasmodic Drugs.
The Anti-spasmodic Drugs market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Anti-spasmodic Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Anti-spasmodic Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Anti-spasmodic Drugs Market Report

Report Metric Details
Report Name Anti-spasmodic Drugs Market
CAGR 5%
Segment by Type
Segment by Application
  • Offline Channel
  • Online Channel
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, Allergan, Ipsen, Teva Pharmaceuticals, Novartis, Johnson & Johnson, Takeda Pharmaceutical, Sun Pharmaceutical Industries, Merz Pharma, Mylan, Fresenius Kabi, Endo International, Daewoong Pharmaceutical, Acorda Therapeutics, SteriMax, Emcure Pharmaceuticals, Sawai Pharmaceutical, Orient Pharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Anti-spasmodic Drugs company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Anti-spasmodic Drugs Market report?

Ans: The main players in the Anti-spasmodic Drugs Market are Pfizer, Allergan, Ipsen, Teva Pharmaceuticals, Novartis, Johnson & Johnson, Takeda Pharmaceutical, Sun Pharmaceutical Industries, Merz Pharma, Mylan, Fresenius Kabi, Endo International, Daewoong Pharmaceutical, Acorda Therapeutics, SteriMax, Emcure Pharmaceuticals, Sawai Pharmaceutical, Orient Pharma

What are the Application segmentation covered in the Anti-spasmodic Drugs Market report?

Ans: The Applications covered in the Anti-spasmodic Drugs Market report are Offline Channel, Online Channel

What are the Type segmentation covered in the Anti-spasmodic Drugs Market report?

Ans: The Types covered in the Anti-spasmodic Drugs Market report are Antimuscarinics, Smooth Muscle Relaxants

Recommended Reports

CNS & Psychiatric Drugs

Muscle & Nerve Drugs

Sleep & Sedative Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Anti-spasmodic Drugs Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Antimuscarinics
1.2.3 Smooth Muscle Relaxants
1.3 Market by Application
1.3.1 Global Anti-spasmodic Drugs Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Offline Channel
1.3.3 Online Channel
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Anti-spasmodic Drugs Market Perspective (2020-2031)
2.2 Global Anti-spasmodic Drugs Growth Trends by Region
2.2.1 Global Anti-spasmodic Drugs Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Anti-spasmodic Drugs Historic Market Size by Region (2020-2025)
2.2.3 Anti-spasmodic Drugs Forecasted Market Size by Region (2026-2031)
2.3 Anti-spasmodic Drugs Market Dynamics
2.3.1 Anti-spasmodic Drugs Industry Trends
2.3.2 Anti-spasmodic Drugs Market Drivers
2.3.3 Anti-spasmodic Drugs Market Challenges
2.3.4 Anti-spasmodic Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Anti-spasmodic Drugs Players by Revenue
3.1.1 Global Top Anti-spasmodic Drugs Players by Revenue (2020-2025)
3.1.2 Global Anti-spasmodic Drugs Revenue Market Share by Players (2020-2025)
3.2 Global Anti-spasmodic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Anti-spasmodic Drugs Revenue
3.4 Global Anti-spasmodic Drugs Market Concentration Ratio
3.4.1 Global Anti-spasmodic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Anti-spasmodic Drugs Revenue in 2024
3.5 Global Key Players of Anti-spasmodic Drugs Head office and Area Served
3.6 Global Key Players of Anti-spasmodic Drugs, Product and Application
3.7 Global Key Players of Anti-spasmodic Drugs, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Anti-spasmodic Drugs Breakdown Data by Type
4.1 Global Anti-spasmodic Drugs Historic Market Size by Type (2020-2025)
4.2 Global Anti-spasmodic Drugs Forecasted Market Size by Type (2026-2031)
5 Anti-spasmodic Drugs Breakdown Data by Application
5.1 Global Anti-spasmodic Drugs Historic Market Size by Application (2020-2025)
5.2 Global Anti-spasmodic Drugs Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Anti-spasmodic Drugs Market Size (2020-2031)
6.2 North America Anti-spasmodic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Anti-spasmodic Drugs Market Size by Country (2020-2025)
6.4 North America Anti-spasmodic Drugs Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Anti-spasmodic Drugs Market Size (2020-2031)
7.2 Europe Anti-spasmodic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Anti-spasmodic Drugs Market Size by Country (2020-2025)
7.4 Europe Anti-spasmodic Drugs Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Anti-spasmodic Drugs Market Size (2020-2031)
8.2 Asia-Pacific Anti-spasmodic Drugs Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Anti-spasmodic Drugs Market Size by Region (2020-2025)
8.4 Asia-Pacific Anti-spasmodic Drugs Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Anti-spasmodic Drugs Market Size (2020-2031)
9.2 Latin America Anti-spasmodic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Anti-spasmodic Drugs Market Size by Country (2020-2025)
9.4 Latin America Anti-spasmodic Drugs Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Anti-spasmodic Drugs Market Size (2020-2031)
10.2 Middle East & Africa Anti-spasmodic Drugs Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Anti-spasmodic Drugs Market Size by Country (2020-2025)
10.4 Middle East & Africa Anti-spasmodic Drugs Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Anti-spasmodic Drugs Introduction
11.1.4 Pfizer Revenue in Anti-spasmodic Drugs Business (2020-2025)
11.1.5 Pfizer Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Allergan Business Overview
11.2.3 Allergan Anti-spasmodic Drugs Introduction
11.2.4 Allergan Revenue in Anti-spasmodic Drugs Business (2020-2025)
11.2.5 Allergan Recent Development
11.3 Ipsen
11.3.1 Ipsen Company Details
11.3.2 Ipsen Business Overview
11.3.3 Ipsen Anti-spasmodic Drugs Introduction
11.3.4 Ipsen Revenue in Anti-spasmodic Drugs Business (2020-2025)
11.3.5 Ipsen Recent Development
11.4 Teva Pharmaceuticals
11.4.1 Teva Pharmaceuticals Company Details
11.4.2 Teva Pharmaceuticals Business Overview
11.4.3 Teva Pharmaceuticals Anti-spasmodic Drugs Introduction
11.4.4 Teva Pharmaceuticals Revenue in Anti-spasmodic Drugs Business (2020-2025)
11.4.5 Teva Pharmaceuticals Recent Development
11.5 Novartis
11.5.1 Novartis Company Details
11.5.2 Novartis Business Overview
11.5.3 Novartis Anti-spasmodic Drugs Introduction
11.5.4 Novartis Revenue in Anti-spasmodic Drugs Business (2020-2025)
11.5.5 Novartis Recent Development
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Details
11.6.2 Johnson & Johnson Business Overview
11.6.3 Johnson & Johnson Anti-spasmodic Drugs Introduction
11.6.4 Johnson & Johnson Revenue in Anti-spasmodic Drugs Business (2020-2025)
11.6.5 Johnson & Johnson Recent Development
11.7 Takeda Pharmaceutical
11.7.1 Takeda Pharmaceutical Company Details
11.7.2 Takeda Pharmaceutical Business Overview
11.7.3 Takeda Pharmaceutical Anti-spasmodic Drugs Introduction
11.7.4 Takeda Pharmaceutical Revenue in Anti-spasmodic Drugs Business (2020-2025)
11.7.5 Takeda Pharmaceutical Recent Development
11.8 Sun Pharmaceutical Industries
11.8.1 Sun Pharmaceutical Industries Company Details
11.8.2 Sun Pharmaceutical Industries Business Overview
11.8.3 Sun Pharmaceutical Industries Anti-spasmodic Drugs Introduction
11.8.4 Sun Pharmaceutical Industries Revenue in Anti-spasmodic Drugs Business (2020-2025)
11.8.5 Sun Pharmaceutical Industries Recent Development
11.9 Merz Pharma
11.9.1 Merz Pharma Company Details
11.9.2 Merz Pharma Business Overview
11.9.3 Merz Pharma Anti-spasmodic Drugs Introduction
11.9.4 Merz Pharma Revenue in Anti-spasmodic Drugs Business (2020-2025)
11.9.5 Merz Pharma Recent Development
11.10 Mylan
11.10.1 Mylan Company Details
11.10.2 Mylan Business Overview
11.10.3 Mylan Anti-spasmodic Drugs Introduction
11.10.4 Mylan Revenue in Anti-spasmodic Drugs Business (2020-2025)
11.10.5 Mylan Recent Development
11.11 Fresenius Kabi
11.11.1 Fresenius Kabi Company Details
11.11.2 Fresenius Kabi Business Overview
11.11.3 Fresenius Kabi Anti-spasmodic Drugs Introduction
11.11.4 Fresenius Kabi Revenue in Anti-spasmodic Drugs Business (2020-2025)
11.11.5 Fresenius Kabi Recent Development
11.12 Endo International
11.12.1 Endo International Company Details
11.12.2 Endo International Business Overview
11.12.3 Endo International Anti-spasmodic Drugs Introduction
11.12.4 Endo International Revenue in Anti-spasmodic Drugs Business (2020-2025)
11.12.5 Endo International Recent Development
11.13 Daewoong Pharmaceutical
11.13.1 Daewoong Pharmaceutical Company Details
11.13.2 Daewoong Pharmaceutical Business Overview
11.13.3 Daewoong Pharmaceutical Anti-spasmodic Drugs Introduction
11.13.4 Daewoong Pharmaceutical Revenue in Anti-spasmodic Drugs Business (2020-2025)
11.13.5 Daewoong Pharmaceutical Recent Development
11.14 Acorda Therapeutics
11.14.1 Acorda Therapeutics Company Details
11.14.2 Acorda Therapeutics Business Overview
11.14.3 Acorda Therapeutics Anti-spasmodic Drugs Introduction
11.14.4 Acorda Therapeutics Revenue in Anti-spasmodic Drugs Business (2020-2025)
11.14.5 Acorda Therapeutics Recent Development
11.15 SteriMax
11.15.1 SteriMax Company Details
11.15.2 SteriMax Business Overview
11.15.3 SteriMax Anti-spasmodic Drugs Introduction
11.15.4 SteriMax Revenue in Anti-spasmodic Drugs Business (2020-2025)
11.15.5 SteriMax Recent Development
11.16 Emcure Pharmaceuticals
11.16.1 Emcure Pharmaceuticals Company Details
11.16.2 Emcure Pharmaceuticals Business Overview
11.16.3 Emcure Pharmaceuticals Anti-spasmodic Drugs Introduction
11.16.4 Emcure Pharmaceuticals Revenue in Anti-spasmodic Drugs Business (2020-2025)
11.16.5 Emcure Pharmaceuticals Recent Development
11.17 Sawai Pharmaceutical
11.17.1 Sawai Pharmaceutical Company Details
11.17.2 Sawai Pharmaceutical Business Overview
11.17.3 Sawai Pharmaceutical Anti-spasmodic Drugs Introduction
11.17.4 Sawai Pharmaceutical Revenue in Anti-spasmodic Drugs Business (2020-2025)
11.17.5 Sawai Pharmaceutical Recent Development
11.18 Orient Pharma
11.18.1 Orient Pharma Company Details
11.18.2 Orient Pharma Business Overview
11.18.3 Orient Pharma Anti-spasmodic Drugs Introduction
11.18.4 Orient Pharma Revenue in Anti-spasmodic Drugs Business (2020-2025)
11.18.5 Orient Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Allergan plc
Ipsen S A
Teva Pharmaceuticals
Novartis
Johnson & Johnson
Takeda Pharmaceutical
Sun Pharmaceutical Industries
Merz Pharma
Mylan NV
Fresenius Kabi
Endo International
Daewoong Pharmaceutical
Acorda Therapeutics
Sterimax
Emcure Pharmaceuticals
Sawai Pharmaceutical
Orient Pharma
Johnson & Johnson
List of Tables
 Table 1. Global Anti-spasmodic Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Antimuscarinics
 Table 3. Key Players of Smooth Muscle Relaxants
 Table 4. Global Anti-spasmodic Drugs Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Anti-spasmodic Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Anti-spasmodic Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Anti-spasmodic Drugs Market Share by Region (2020-2025)
 Table 8. Global Anti-spasmodic Drugs Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Anti-spasmodic Drugs Market Share by Region (2026-2031)
 Table 10. Anti-spasmodic Drugs Market Trends
 Table 11. Anti-spasmodic Drugs Market Drivers
 Table 12. Anti-spasmodic Drugs Market Challenges
 Table 13. Anti-spasmodic Drugs Market Restraints
 Table 14. Global Anti-spasmodic Drugs Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Anti-spasmodic Drugs Market Share by Players (2020-2025)
 Table 16. Global Top Anti-spasmodic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-spasmodic Drugs as of 2024)
 Table 17. Ranking of Global Top Anti-spasmodic Drugs Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Anti-spasmodic Drugs Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Anti-spasmodic Drugs, Headquarters and Area Served
 Table 20. Global Key Players of Anti-spasmodic Drugs, Product and Application
 Table 21. Global Key Players of Anti-spasmodic Drugs, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Anti-spasmodic Drugs Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Anti-spasmodic Drugs Revenue Market Share by Type (2020-2025)
 Table 25. Global Anti-spasmodic Drugs Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Anti-spasmodic Drugs Revenue Market Share by Type (2026-2031)
 Table 27. Global Anti-spasmodic Drugs Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Anti-spasmodic Drugs Revenue Market Share by Application (2020-2025)
 Table 29. Global Anti-spasmodic Drugs Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Anti-spasmodic Drugs Revenue Market Share by Application (2026-2031)
 Table 31. North America Anti-spasmodic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Anti-spasmodic Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Anti-spasmodic Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Anti-spasmodic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Anti-spasmodic Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Anti-spasmodic Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Anti-spasmodic Drugs Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Anti-spasmodic Drugs Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Anti-spasmodic Drugs Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Anti-spasmodic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Anti-spasmodic Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Anti-spasmodic Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Anti-spasmodic Drugs Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Anti-spasmodic Drugs Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Anti-spasmodic Drugs Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Pfizer Company Details
 Table 47. Pfizer Business Overview
 Table 48. Pfizer Anti-spasmodic Drugs Product
 Table 49. Pfizer Revenue in Anti-spasmodic Drugs Business (2020-2025) & (US$ Million)
 Table 50. Pfizer Recent Development
 Table 51. Allergan Company Details
 Table 52. Allergan Business Overview
 Table 53. Allergan Anti-spasmodic Drugs Product
 Table 54. Allergan Revenue in Anti-spasmodic Drugs Business (2020-2025) & (US$ Million)
 Table 55. Allergan Recent Development
 Table 56. Ipsen Company Details
 Table 57. Ipsen Business Overview
 Table 58. Ipsen Anti-spasmodic Drugs Product
 Table 59. Ipsen Revenue in Anti-spasmodic Drugs Business (2020-2025) & (US$ Million)
 Table 60. Ipsen Recent Development
 Table 61. Teva Pharmaceuticals Company Details
 Table 62. Teva Pharmaceuticals Business Overview
 Table 63. Teva Pharmaceuticals Anti-spasmodic Drugs Product
 Table 64. Teva Pharmaceuticals Revenue in Anti-spasmodic Drugs Business (2020-2025) & (US$ Million)
 Table 65. Teva Pharmaceuticals Recent Development
 Table 66. Novartis Company Details
 Table 67. Novartis Business Overview
 Table 68. Novartis Anti-spasmodic Drugs Product
 Table 69. Novartis Revenue in Anti-spasmodic Drugs Business (2020-2025) & (US$ Million)
 Table 70. Novartis Recent Development
 Table 71. Johnson & Johnson Company Details
 Table 72. Johnson & Johnson Business Overview
 Table 73. Johnson & Johnson Anti-spasmodic Drugs Product
 Table 74. Johnson & Johnson Revenue in Anti-spasmodic Drugs Business (2020-2025) & (US$ Million)
 Table 75. Johnson & Johnson Recent Development
 Table 76. Takeda Pharmaceutical Company Details
 Table 77. Takeda Pharmaceutical Business Overview
 Table 78. Takeda Pharmaceutical Anti-spasmodic Drugs Product
 Table 79. Takeda Pharmaceutical Revenue in Anti-spasmodic Drugs Business (2020-2025) & (US$ Million)
 Table 80. Takeda Pharmaceutical Recent Development
 Table 81. Sun Pharmaceutical Industries Company Details
 Table 82. Sun Pharmaceutical Industries Business Overview
 Table 83. Sun Pharmaceutical Industries Anti-spasmodic Drugs Product
 Table 84. Sun Pharmaceutical Industries Revenue in Anti-spasmodic Drugs Business (2020-2025) & (US$ Million)
 Table 85. Sun Pharmaceutical Industries Recent Development
 Table 86. Merz Pharma Company Details
 Table 87. Merz Pharma Business Overview
 Table 88. Merz Pharma Anti-spasmodic Drugs Product
 Table 89. Merz Pharma Revenue in Anti-spasmodic Drugs Business (2020-2025) & (US$ Million)
 Table 90. Merz Pharma Recent Development
 Table 91. Mylan Company Details
 Table 92. Mylan Business Overview
 Table 93. Mylan Anti-spasmodic Drugs Product
 Table 94. Mylan Revenue in Anti-spasmodic Drugs Business (2020-2025) & (US$ Million)
 Table 95. Mylan Recent Development
 Table 96. Fresenius Kabi Company Details
 Table 97. Fresenius Kabi Business Overview
 Table 98. Fresenius Kabi Anti-spasmodic Drugs Product
 Table 99. Fresenius Kabi Revenue in Anti-spasmodic Drugs Business (2020-2025) & (US$ Million)
 Table 100. Fresenius Kabi Recent Development
 Table 101. Endo International Company Details
 Table 102. Endo International Business Overview
 Table 103. Endo International Anti-spasmodic Drugs Product
 Table 104. Endo International Revenue in Anti-spasmodic Drugs Business (2020-2025) & (US$ Million)
 Table 105. Endo International Recent Development
 Table 106. Daewoong Pharmaceutical Company Details
 Table 107. Daewoong Pharmaceutical Business Overview
 Table 108. Daewoong Pharmaceutical Anti-spasmodic Drugs Product
 Table 109. Daewoong Pharmaceutical Revenue in Anti-spasmodic Drugs Business (2020-2025) & (US$ Million)
 Table 110. Daewoong Pharmaceutical Recent Development
 Table 111. Acorda Therapeutics Company Details
 Table 112. Acorda Therapeutics Business Overview
 Table 113. Acorda Therapeutics Anti-spasmodic Drugs Product
 Table 114. Acorda Therapeutics Revenue in Anti-spasmodic Drugs Business (2020-2025) & (US$ Million)
 Table 115. Acorda Therapeutics Recent Development
 Table 116. SteriMax Company Details
 Table 117. SteriMax Business Overview
 Table 118. SteriMax Anti-spasmodic Drugs Product
 Table 119. SteriMax Revenue in Anti-spasmodic Drugs Business (2020-2025) & (US$ Million)
 Table 120. SteriMax Recent Development
 Table 121. Emcure Pharmaceuticals Company Details
 Table 122. Emcure Pharmaceuticals Business Overview
 Table 123. Emcure Pharmaceuticals Anti-spasmodic Drugs Product
 Table 124. Emcure Pharmaceuticals Revenue in Anti-spasmodic Drugs Business (2020-2025) & (US$ Million)
 Table 125. Emcure Pharmaceuticals Recent Development
 Table 126. Sawai Pharmaceutical Company Details
 Table 127. Sawai Pharmaceutical Business Overview
 Table 128. Sawai Pharmaceutical Anti-spasmodic Drugs Product
 Table 129. Sawai Pharmaceutical Revenue in Anti-spasmodic Drugs Business (2020-2025) & (US$ Million)
 Table 130. Sawai Pharmaceutical Recent Development
 Table 131. Orient Pharma Company Details
 Table 132. Orient Pharma Business Overview
 Table 133. Orient Pharma Anti-spasmodic Drugs Product
 Table 134. Orient Pharma Revenue in Anti-spasmodic Drugs Business (2020-2025) & (US$ Million)
 Table 135. Orient Pharma Recent Development
 Table 136. Research Programs/Design for This Report
 Table 137. Key Data Information from Secondary Sources
 Table 138. Key Data Information from Primary Sources
 Table 139. Authors List of This Report


List of Figures
 Figure 1. Anti-spasmodic Drugs Picture
 Figure 2. Global Anti-spasmodic Drugs Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Anti-spasmodic Drugs Market Share by Type: 2024 VS 2031
 Figure 4. Antimuscarinics Features
 Figure 5. Smooth Muscle Relaxants Features
 Figure 6. Global Anti-spasmodic Drugs Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Anti-spasmodic Drugs Market Share by Application: 2024 VS 2031
 Figure 8. Offline Channel Case Studies
 Figure 9. Online Channel Case Studies
 Figure 10. Anti-spasmodic Drugs Report Years Considered
 Figure 11. Global Anti-spasmodic Drugs Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Anti-spasmodic Drugs Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Anti-spasmodic Drugs Market Share by Region: 2024 VS 2031
 Figure 14. Global Anti-spasmodic Drugs Market Share by Players in 2024
 Figure 15. Global Top Anti-spasmodic Drugs Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-spasmodic Drugs as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Anti-spasmodic Drugs Revenue in 2024
 Figure 17. North America Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Anti-spasmodic Drugs Market Share by Country (2020-2031)
 Figure 19. United States Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Anti-spasmodic Drugs Market Share by Country (2020-2031)
 Figure 23. Germany Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Anti-spasmodic Drugs Market Share by Region (2020-2031)
 Figure 31. China Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Anti-spasmodic Drugs Market Share by Country (2020-2031)
 Figure 39. Mexico Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Anti-spasmodic Drugs Market Share by Country (2020-2031)
 Figure 43. Turkey Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Anti-spasmodic Drugs Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Pfizer Revenue Growth Rate in Anti-spasmodic Drugs Business (2020-2025)
 Figure 47. Allergan Revenue Growth Rate in Anti-spasmodic Drugs Business (2020-2025)
 Figure 48. Ipsen Revenue Growth Rate in Anti-spasmodic Drugs Business (2020-2025)
 Figure 49. Teva Pharmaceuticals Revenue Growth Rate in Anti-spasmodic Drugs Business (2020-2025)
 Figure 50. Novartis Revenue Growth Rate in Anti-spasmodic Drugs Business (2020-2025)
 Figure 51. Johnson & Johnson Revenue Growth Rate in Anti-spasmodic Drugs Business (2020-2025)
 Figure 52. Takeda Pharmaceutical Revenue Growth Rate in Anti-spasmodic Drugs Business (2020-2025)
 Figure 53. Sun Pharmaceutical Industries Revenue Growth Rate in Anti-spasmodic Drugs Business (2020-2025)
 Figure 54. Merz Pharma Revenue Growth Rate in Anti-spasmodic Drugs Business (2020-2025)
 Figure 55. Mylan Revenue Growth Rate in Anti-spasmodic Drugs Business (2020-2025)
 Figure 56. Fresenius Kabi Revenue Growth Rate in Anti-spasmodic Drugs Business (2020-2025)
 Figure 57. Endo International Revenue Growth Rate in Anti-spasmodic Drugs Business (2020-2025)
 Figure 58. Daewoong Pharmaceutical Revenue Growth Rate in Anti-spasmodic Drugs Business (2020-2025)
 Figure 59. Acorda Therapeutics Revenue Growth Rate in Anti-spasmodic Drugs Business (2020-2025)
 Figure 60. SteriMax Revenue Growth Rate in Anti-spasmodic Drugs Business (2020-2025)
 Figure 61. Emcure Pharmaceuticals Revenue Growth Rate in Anti-spasmodic Drugs Business (2020-2025)
 Figure 62. Sawai Pharmaceutical Revenue Growth Rate in Anti-spasmodic Drugs Business (2020-2025)
 Figure 63. Orient Pharma Revenue Growth Rate in Anti-spasmodic Drugs Business (2020-2025)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
 Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Dicyclomine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antispasmodics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antispasmodics Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Antispasmodic and Anticholinergic H2 Blocking Agents Market Research Report 2024
Hyoscyamine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Hyoscine N Butyl Bromide Market Insights Forecast to 2030
Global IBS C Drugs Market Research Report 2024
Global Hyoscyamine Sulfate Injection Market Research Report 2024
Global Rx Irritable Bowel Syndrome IBS Drugs Market Insights Forecast to 2030
Global Ciclobenzaprina Market Research Report 2024
Global Drotaverine HCL Market Research Report 2024
Muscle Relaxants Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Levocetirizine Hydrochloride Capsules Market Research Report 2024
Global Levocetirizine Hydrochloride Tablets Market Research Report 2024
Global Blepharospasm Therapeutic Market Research Report 2025
Global Bendazol Tablets Market Research Report 2024
Global Central Muscle Relaxants Market Research Report 2025
Global Alibendol Market Research Report 2024
Global Idiopathic Gastroparesis Drugs Market Insights Forecast to 2030
Irritable Bowel Syndrome Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Long-Acting HIV-1 Inhibitors Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19B19893
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Methylphenidate Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30B3636
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Soliris Intravenous Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3H1702
Thu Sep 11 00:00:00 UTC 2025

Add to Cart

Global Mouth Ulcers Drugs Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13C3384
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions